Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model.
JMIR Res Protoc
; 12: e43091, 2023 Mar 08.
Article
en En
| MEDLINE
| ID: mdl-36884286
Kirkpatrick; Kirkpatrick model; care pathway; community health; community pharma; cross-sectional; dispensary; dispensation; dispense; dispensing; e learn; e-learning; emicizumab; healthcare management; hemophilia; hospital pharma; knowledge acquisition; learning; patient satisfaction; pharma; pharmaceutic; pharmacist; pharmacy; prophylaxis; questionnaire; survey
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Guideline
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Idioma:
En
Revista:
JMIR Res Protoc
Año:
2023
Tipo del documento:
Article
País de afiliación:
Francia
Pais de publicación:
Canadá